Multiple Cancers
Deciphering the oncogenic properties of cancer-associated IDH1/2 mutations
TFRI New Investigator Dr. Frédérick Mallette is breaking new ground in his efforts to characterize metabolic defects associated with brain cancer and leukemia, paving the way for new app...
Read More